74and Regenerative Medicine (ISCBRM) have been collaborat-ing since 2017. This year, we had the 4th joint symposium, which was originally planned to be held at the RIKEN Yokohama cam-pus. However, because of the COVID-19 pandemic, the meeting was rescheduled and the venue was moved to online. Due to the time-zone difference between Japan and California, the duration of the meeting was much shorter than usual, just 3 hours a day. Despite such limitations, it turned out that we enjoyed deep and productive discussions throughout the symposium. Since the number of presentation slots was limited, speakers were selected from among the young investigators (Photo), and this might have been the key for active discussion. From RIKEN IMS; Kazuki Okuyama, Natsuko Otaki, Saumya Agrawal, Yan Jun Lan, and Long Guo presented their latest projects. From Stanford ISCBRM; Rahul Sinha, Agnieszka Czechowiez, Aaron Newman, Carolyn Dundes, Gerlinde Wernig, and Charles Chan gave talks on their cutting-edge research. Topics included immunology, hematology, organoids, brain development, bioinformatics, and bone biology. About 70 participants in total from both sides joined each day, Medicine have established close interactions to pursue re-search in the areas of genomics, immunology, and cancer across a broad range of diseases. The first comprehensive cooperation agreements/MOUs between the two institutes were even earlier, in July 2010. Starting from the first symposium, which was held May 2017 at McGill University, Montreal, Canada, we had two other symposia - in February 2018 at Yokohama, Japan and in November 2019 at Montreal. These past symposia encompassed the research areas of genome biology, including human genome medicine, immunology and infectious disease and cancers. The fourth symposium was planned for 6th-7th April 2020 at Yo-kohama; however, it was postponed because of the world-wide pandemic of SARS-CoV-2 from March 2020. Meanwhile, we were fortunate to obtain financial support from RIKEN and AMED for the RIKEN IMS-McGill partnership, so we decided to orga-nize a virtual on-line symposium on 26th-27th January 2021 to exchange information and to discuss how we will advance this international collaborative activity. Despite the 14 hour time dif-ference between the two sites, the 4th on-line symposium had 200 registrants and 120-140 participants on average in each session. On the second day, two PhD students presented their outstand-and very active discussion occurred after each talk over the Pa-cific! Although we missed the social events like in previous years, it was quite productive to know that we could enjoy exchanging scientific ideas over the web-meeting. The next joint symposium will take place in 2021, hopefully on the Stanford Campus.ing work and two junior PIs jointly presented their research plan funded by AMED. This was followed by a panel discussion ses-sion about how the two organizations will support this interna-tional activity at both laboratory and institutional level, and how we will stimulate human exchange.RIKEN IMS-Stanford ISCBRM Joint SymposiumRIKEN IMS and the Stanford Institute of Stem Cell Biology RIKEN-McGill SymposiumsSince 2016, RIKEN IMS and the McGill University Faculty of
元のページ ../index.html#80